(Ch25) Eosinophilic dermatoses Flashcards
DDx EOSINOPHILIC SPONGIOSIS ?
HAAAPPPIED
Herpes gestationis
Arthropod bite
ACD
AD
Pemphigus
Pemphigoid
Polymorphous eruption of pregnancy (PEP)
Incontinentia pigmenti (stage 1 and 2)
Erythema toxicum
Drug
GROWTH FACTORS for Eosin
- IL-3
- GM-CSF
- IL-5
Most potent growth factor for Eosin
GM-CSF
Most Selective growth factor for Eosin
IL-5: JAK2/STAT5 pathway
Factors chemoattract/recurit Eosin to tissue
- Platelet activaing factor (PAF)
- CCL11 (eotaxin),
- CCL24 (eotaxin 2),
- CCL26 (eotaxin3)
Most potent eosin chemoattractant
Platelet activaing factor (PAF)
Release of Eosin granules in 3 ways mention them?
- cytolytic degranulation - organelle rupture,
- Piecemeal degranulation
- Exocytosis
Eosin Primary Granules
Charcot Leyden crystal (Galactin-10)
Eosin 2˚/Secretory Granules 5 components
Major basic protein 1
Major basic protein 2
Eosinophil derived neurotoxin
Eosinophil catonic protein
Eosinophil peroxidase (most numerous)
Eosin Small granules
Acid phosphatase
Arylsulfatase
Eosin Secretory vesicles
Albumin
Eosin Non-membrane bound lipid bodies
Arachidonic acid
Cyclooxygenease
5&15 lipooxygenase
LTC4
Ddx for PSEUDOCELLULITIS
- Infections and bites
- Arthropod bite reactions (e.g. insect, spider)
-Erythema migrans
-Herpes zoster
-Toxin-mediated erythema (e.g. recurrent toxin-mediated perineal erythema
- Neutrophilic dermatoses
- Sweet’s syndrome
- Neutrophilic panniculitis (Pancreatic, Facticial)
- Familial Mediterranean fever
- Arthropod bite reactions (e.g. insect, spider)
- Drug reactions
- Fixed drug eruptions (esp Non-Pigmenting Adverse rx: NSAIDs, Pseudoepherine, Acetaminophen)
- Vaccine/injection site reactions
- Toxic erythema of chemotherapy
- Metabolic disorders
Gout - Malignancy
Erysipeloid skin metastases
ddx for persistent red facial plaque with epidermal changes
DLE
Subacute SLE
Tinea
SD
Perioral dermatitis
BCC
SCC
Leprosy
ddx for persistent red facial plaque without epidermal changes
LLLLLL
Lymphoma
Leukemia cutis
Lupus tumidus
Polymorphous Light Eruption
Lyme
syphilis
Granuloma faciale
Granuloma faciale clinical appearance
Prominent follicular openings
2/3 solitary
Granuloma faciale variant with Sinonasal mucosal involvement
esoinophilic angiocentric fibrosis
Typical histopath of Granuloma faciale
Grenz zone
+ LCV, Eosin, neut
Grenz zone ddx
lymphoma/leukemia
Granuloma faciale
Erythema elevatum diutinum
Rx for Granuloma faciale
Resistant
Intralesional triamcinolone (2.5-5mg/ml)
Dapsone (50-150 mg/d)
Clofazimine (300mg daily) - ?availability
Topical PUVA or calcineurin inhbitors
Physical: excision, cryosurgery, dermabrasion, electrosurgery and CO2 or 595 PDL can recur
which patients are at higher risk/ As/w Exaggerated Insect Bite and Insect Bite-Like reactions
CLL > other myeloproliferative disorders
EBV associated NK/T-cell lymphoma, nasal type